France considers breast screening for 40-49 age group
This article was originally published in Clinica
The French national healthcare accreditation and evaluation agency, Anaes, has advised its government that there is still not enough evidence to suggest that it is worth extending the French national breast cancer screening programme to women aged between 40 and 49. Screening is currently offered every other year to those aged between 50 and 74.
You may also be interested in...
Despite a reprieve last summer from the Trump administration’s proposed drug price rebate rule, speakers at the 25th annual Pharmacy Benefit Manager Institute kept the focus on price transparency and talked up new ways to manage drug costs for patients in need of treatment.
Taking over at the Swiss firm as CEO in 2018, Vas Narasimhan set about creating an "inspired, curious and unbossed organization." Two years on, he has put the spotlight on several initiatives that are up and running on a number of fronts to achieve that goal.
The AAM has outlined a set of principles that it says will help protect patient access to generics and biosimilars and aid in efforts to diversify the supply chain to help mitigate future crises. The association said it would work with policymakers and other stakeholders to formulate policies to address concerns that the coronavirus pandemic has raised.